Ali Behbahani - 06 Jun 2022 Form 4 Insider Report for Oyster Point Pharma, Inc.

Role: Director
Signature: /s/ Louis Citron, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 06 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 08 Jun 2022, 16:49:53 UTC
Previous filing: 26 May 2022
Next filing: 09 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OYST	Common Stock	Award	$0	+3,573	+35%	$0.000000	13,639	06 Jun 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OYST	Stock Option (Right to Buy)	Award	$0	+5,359		$0.000000	5,359	06 Jun 2022	Common Stock	5,359	$3.63	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of Restricted Stock Units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
F2	The shares underlying each RSU will vest on June 6, 2023, but will vest fully on the date of the next annual stockholder meeting held after the date of the grant if not fully vested on such date, in each case, subject to the Reporting Person's continuous service to the issue as a director through each such date.
F3	The shares underlying the option vest as to one-twelfth (1/12th) of the shares on July 6, 2022 and monthly thereafter on the same day of the month as the grant date, in each case, subject to the Reporting Person's continuous service to the Issuer as a director through each such date.